danazol has been researched along with Autoimmune Lymphoproliferative Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farkas, H; Kőhalmi, KV; Luczay, A; Varga, L; Veszeli, N | 1 |
| Csuka, D; Czaller, I; Farkas, H; Füst, G; Harmat, G; Jakab, L; Karádi, I; Prohászka, Z; Széplaki, G; Valentin, S; Varga, L; Vas, A; Visy, B | 1 |
2 other study(ies) available for danazol and Autoimmune Lymphoproliferative Syndrome
| Article | Year |
|---|---|
[Effect of danazol treatment on growth in pediatric patients with hereditary angioedema due to C1-inhibitor deficiency].
Topics: Adolescent; Angioedemas, Hereditary; Autoimmune Lymphoproliferative Syndrome; Child; Complement C1 Inhibitor Protein; Danazol; Estrogen Antagonists; Female; Growth Disorders; Humans; Male; Retrospective Studies; Risk Factors | 2017 |
The effect of long-term danazol prophylaxis on liver function in hereditary angioedema-a longitudinal study.
Topics: Angioedemas, Hereditary; Autoimmune Lymphoproliferative Syndrome; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Danazol; Humans; Liver Diseases; Liver Function Tests; Longitudinal Studies | 2010 |